Immune stimulation by phosphorothioate oligonucleotide analogs

Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 44, 424 173, 424 177, 4242801, 536 231, 536 243, 536 2431, 536 2433, C12N 510, A61K 3170, A61K 31795, C07H 2100

Patent

active

057233357

ABSTRACT:
Methods of stimulating a local immune response in selected cells or tissues employing immunopotentiating oligonucleotide analogs having at least one phosphorothioate internucleotide bond are provided. Methods of enhancing the efficacy of a therapeutic treatment by stimulating a local immune response in selected cells or tissues employing oligonucleotide analogs having at least one phosphorothioate bond are also provided. The oligonucleotide analogs may have antisense efficacy in addition to immunopotentiating activity. Methods of modulating cytokine release in skin cells and immunopotentiators which include oligonucleotide analogs having at least one phosphorothioate bond capable of eliciting a local inflammatory response are also provided.

REFERENCES:
patent: 5248670 (1993-09-01), Draper et al.
patent: 5457189 (1995-10-01), Crooke et al.
patent: 5506212 (1996-04-01), Hoke et al.
patent: 5514577 (1996-05-01), Draper et al.
patent: 5576208 (1996-11-01), Monia et al.
patent: 5582986 (1996-12-01), Monia et al.
Crooke et al. Toxical. & Appl. Pharmacol. 140(1) :85-93 ('96) Biosis Abstract.
Bickel et al. J. Dental Res. 75(11) :1827-34 ('96) Biosis Abstract.
P. Lagrange et al., Chapter 16 in Immunology, 2.sup.nd Ed., ed. by J.-F. Bach & R. Schwartz (NY, John Wiley & Sons, 1982) pp. 465-501.
A. Eskelinen et al. (abstract) Drugs, vol. 34 #5 (Nov. '87) pp. 599-603.
B. O'Neill et al. Cancer Derecr. Preven., vol. 12 .sup.# 1-6 ('88) pp. 497-501.
H. Abken et al. J. Immunol., vol. 149 .sup.# 8 (Oct. 15, 1992) pp. 2785-2794.
T. Kupper et al. J. Clin. Invent., vol. 82 (Nov. 1988) pp. 1787-1792.
Branda, R.F. et al., Immune Stimulation by an Antisense Oligomer Complementary to the rev Gene of HIV-1, Biochemical Pharmacology, 1993, 45, 2037-2043.
Gerwirtz, A.M. et al., G.sub. /S Transition in Normal Human T-Lymphocytes Requires the Nuclear Protein Encoded by c-myb, Scinece 1989, 245, 180-183.
Jachimczak, P. et al., The effect of transforming growth factor-.beta..sub.2 -specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma, J. Neurosurg, 1993, 78, 944-951.
Kloc, M. et al., Interleukin-2 Antisense Oligonucleotides Inhibit in vitro Functions of T Cells, Faseb J., 1991, 5, A973.
Krieg, A.M. et al., A Role for Endogenous Retroviral Sequences in the Regulation of Lymphocyte Activation, J. Immun., 1989, 143, 2448-2451.
Kuramoto, E. et al., Oligonucleotide Sequences Required for Natural Killer Cell Activation, Jpn. J. Cancer Res., 1992, 83, 1128-1131.
McIntyre, K.W. et al., A Sense Phosphorothioate Oligonucleotide Directed to the Initiation Codon of Transcription Factor NF-.kappa.K p65 Causes Sequence-Specific Immune Stimulation, Antisense Research and Development, 1993, 3, 309-322.
Pisetsky, D.S. et al., Stimulation of Murine Lymphocyte Proliferation by a Phosphorothioate Oligonucleotide with Antisense Activity for Herpes Simplex Virus, Life Sciences, 1994, 54, 101-107.
Rodgers, K.E., et al., An international journal concerned with the effects of chemicals on living systems, Toxicology, 1988, 54 241-253.
Rodgers, K.E., et al., Investigations into the Mechanism of Immunosuppression Caused by Acute Treatment with O,O,S-Trimethyl Phosphorothioate: Generation of Suppression Macrophages from Treated Animals, Toxicology and Applied Pharmacology, 1987, 88, 270-281.
A. Allison et al. Molecular Immunology, vol. 28 .sup.# 3 ('91) pp. 279-284.
P. Iverson Anti-Cancer Drug Design, vol. 6 ('91) pp. 531-538.
C. Mojcik et al. Clin. Immunol. & Immuno path., vol. 67 .sup.# 2 ('93) pp. 130-136.
L. Cowsert et al. Antimicrobial Agents & Chemth., vol. 37.sup.# 2 (Feb. 1993) pp. 171-177.
T. Gura, Science, vol. 270 (Oct. 27, 1995) 575-7.
S. James et al., The J. of Immunol., vol. 140(8) (Apr. 15, 1988) 2753-7.
B. Monia et al., The J. of Biol. Chem. 267(28) (Oct. 5, 1992) 19954-62.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Immune stimulation by phosphorothioate oligonucleotide analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immune stimulation by phosphorothioate oligonucleotide analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immune stimulation by phosphorothioate oligonucleotide analogs will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2246784

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.